Calciphylaxis is a rare but serious condition in which microvessel occlusion occurs within the subcutaneous adipose tissue and dermis, leading to painful lesions. End-stage renal disease requiring hemodialysis and warfarin therapy can increase the risk of calciphylaxis. In this report, we describe the evaluation and treatment of a 75-year-old female patient with warfarin-induced calciphylaxis who presented unique symptoms. The patient required intensive care unit admission due to hemodynamic instability, which was treated with inotropes and broad-spectrum intravenous antibiotics. This description of the patient’s unusual symptoms has the potential to provide insights needed to improve the diagnosis of future patients. Due to the unavailability of FDA-approved treatment for calciphylaxis, its management is based on data from observational studies and clinical experience.
CITATION STYLE
Alasmari, M. M., Alsheikh, M. Y., & Metwali, H. H. (2022). Successful Treatment Using Apixaban in a Patient on Hemodialysis with Uremic Calciphylaxis. Clinical, Cosmetic and Investigational Dermatology, 15, 2329–2333. https://doi.org/10.2147/CCID.S382503
Mendeley helps you to discover research relevant for your work.